Apaf-1 is a transcriptional target for E2F and p53

被引:0
|
作者
M. Cristina Moroni
Emma S. Hickman
Eros Lazzerini Denchi
Greta Caprara
Elena Colli
Francesco Cecconi
Heiko Müller
Kristian Helin
机构
[1] European Institute of Oncology,Department of Experimental Oncology
[2] Max-Planck-Institute of Biophysical Chemistry,Department of Molecular Cell Biology
[3] Università degli studi 'Tor Vergata',Department of Biology
[4] Pharmacia Corporation,undefined
来源
Nature Cell Biology | 2001年 / 3卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Loss of function of the retinoblastoma protein, pRB, leads to lack of differentiation, hyperproliferation and apoptosis. Inactivation of pRB results in deregulated E2F activity, which in turn induces entry to S-phase and apoptosis. Induction of apoptosis by either the loss of pRB or the deregulation of E2F activity occurs via both p53-dependent and p53-independent mechanisms. The mechanism by which E2F induces apoptosis is still unclear. Here we show that E2F1 directly regulates the expression of Apaf-1, the gene for apoptosis protease-activating factor 1. These results provide a direct link between the deregulation of the pRB pathway and apoptosis. Furthermore, because the pRB pathway is functionally inactivated in most cancers, the identification of Apaf-1 as a transcriptional target for E2F might explain the increased sensitivity of tumour cells to chemotherapy. We also show that, independently of the pRB pathway, Apaf-1 is a direct transcriptional target of p53, suggesting that p53 might sensitize cells to apoptosis by increasing Apaf-1 levels.
引用
收藏
页码:552 / 558
页数:6
相关论文
共 50 条
  • [31] THE INTERACTION OF RB WITH E2F COINCIDES WITH AN INHIBITION OF THE TRANSCRIPTIONAL ACTIVITY OF E2F
    HIEBERT, SW
    CHELLAPPAN, SP
    HOROWITZ, JM
    NEVINS, JR
    GENES & DEVELOPMENT, 1992, 6 (02) : 177 - 185
  • [32] APAF-1 is a mediator of E2F-1-induced apoptosis in hematopoietic cells.
    Furukawa, Y
    Nishimura, N
    Kano, Y
    Nakamura, M
    BLOOD, 2001, 98 (11) : 758A - 759A
  • [33] E2F1 induces phosphorylation of p53 that is coincident with p53 accumulation and apoptosis
    Rogoff, HA
    Pickering, MT
    Debatis, ME
    Jones, S
    Kowalik, TF
    MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (15) : 5308 - 5318
  • [34] F-box protein Skp2: a novel transcriptional target of E2F
    Zhang, L
    Wang, C
    ONCOGENE, 2006, 25 (18) : 2615 - 2627
  • [35] F-box protein Skp2: a novel transcriptional target of E2F
    L Zhang
    C Wang
    Oncogene, 2006, 25 : 2615 - 2627
  • [36] Functional interplay between p53 and E2F through co-activator p300
    Lee, CW
    Sorensen, TS
    Shikama, N
    La Thangue, NB
    ONCOGENE, 1998, 16 (21) : 2695 - 2710
  • [37] Functional interplay between p53 and E2F through co-activator p300
    Chang-Woo Lee
    Troels S Sørensen
    Noriko Shikama
    Nicholas B La Thangue
    Oncogene, 1998, 16 : 2695 - 2710
  • [38] Gene therapy for gliomas: p53 and E2F-1 proteins and the target of apoptosis (Review)
    Gomez-Manzano, C
    Fueyo, J
    Alameda, F
    Kyritsis, AP
    Yung, WKA
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 1999, 3 (01) : 81 - 85
  • [39] The atypical E2F family member E2F7 couples the p53 and RB pathways during cellular senescence
    Aksoy, Ozlem
    Chicas, Agustin
    Zeng, Tianying
    Zhao, Zhen
    McCurrach, Mila
    Wang, Xiaowo
    Lowe, Scott W.
    GENES & DEVELOPMENT, 2012, 26 (14) : 1546 - 1557
  • [40] Deregulated LAP2α Expression in Cervical Cancer Associates with Aberrant E2F and p53 Activities
    Ward, Michelle C.
    van der Watt, Pauline J.
    Tzoneva, Gannie
    Leaner, Virna D.
    IUBMB LIFE, 2011, 63 (11) : 1018 - 1026